Difficulty: Medium
Average Score: 91%
Practice
In Langerhans cell histiocytosis (LCH), all the following manifestations are at high risk of mortality in patients EXCEPT
Correct answer
C
Rationale
In Langerhans cell histiocytosis (LCH), all the following manifestations are at high risk of mortality in patients EXCEPT the lung (Option C). The correct answer is C because lung involvement in LCH is typically associated with a more favorable prognosis compared to involvement of other organs such as the liver, spleen, and hematopoietic system.
The liver (Option A), spleen (Option B), and hematopoietic system (Option D) are high-risk sites for LCH-related complications and mortality due to potential organ dysfunction, hematologic abnormalities, and systemic implications. In contrast, lung involvement in LCH generally has a better prognosis and lower mortality risk.
In an educational context, understanding the specific organ involvement and associated risks in LCH is crucial for healthcare providers managing pediatric patients with this condition. By knowing that lung involvement does not carry the same high mortality risk as other organ involvement, clinicians can tailor their treatment approaches and prognostic discussions accordingly to optimize patient care outcomes.
The liver (Option A), spleen (Option B), and hematopoietic system (Option D) are high-risk sites for LCH-related complications and mortality due to potential organ dysfunction, hematologic abnormalities, and systemic implications. In contrast, lung involvement in LCH generally has a better prognosis and lower mortality risk.
In an educational context, understanding the specific organ involvement and associated risks in LCH is crucial for healthcare providers managing pediatric patients with this condition. By knowing that lung involvement does not carry the same high mortality risk as other organ involvement, clinicians can tailor their treatment approaches and prognostic discussions accordingly to optimize patient care outcomes.